Cargando…

A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom

Detalles Bibliográficos
Autores principales: Schrautzer, Christoph, Arzt‐Gradwohl, Lisa, Bokanovic, Danijela, Schwarz, Ines, Čerpes, Urban, Koch, Lukas, Herzog, Sereina Annik, Laipold, Karin, Binder, Barbara, Aberer, Werner, Sturm, Gunter Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078896/
https://www.ncbi.nlm.nih.gov/pubmed/31394011
http://dx.doi.org/10.1111/all.14012
_version_ 1783507713600258048
author Schrautzer, Christoph
Arzt‐Gradwohl, Lisa
Bokanovic, Danijela
Schwarz, Ines
Čerpes, Urban
Koch, Lukas
Herzog, Sereina Annik
Laipold, Karin
Binder, Barbara
Aberer, Werner
Sturm, Gunter Johannes
author_facet Schrautzer, Christoph
Arzt‐Gradwohl, Lisa
Bokanovic, Danijela
Schwarz, Ines
Čerpes, Urban
Koch, Lukas
Herzog, Sereina Annik
Laipold, Karin
Binder, Barbara
Aberer, Werner
Sturm, Gunter Johannes
author_sort Schrautzer, Christoph
collection PubMed
description
format Online
Article
Text
id pubmed-7078896
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70788962020-03-19 A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom Schrautzer, Christoph Arzt‐Gradwohl, Lisa Bokanovic, Danijela Schwarz, Ines Čerpes, Urban Koch, Lukas Herzog, Sereina Annik Laipold, Karin Binder, Barbara Aberer, Werner Sturm, Gunter Johannes Allergy Letters to the Editor John Wiley and Sons Inc. 2019-09-03 2020-03 /pmc/articles/PMC7078896/ /pubmed/31394011 http://dx.doi.org/10.1111/all.14012 Text en © 2020 The Authors. Allergy Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letters to the Editor
Schrautzer, Christoph
Arzt‐Gradwohl, Lisa
Bokanovic, Danijela
Schwarz, Ines
Čerpes, Urban
Koch, Lukas
Herzog, Sereina Annik
Laipold, Karin
Binder, Barbara
Aberer, Werner
Sturm, Gunter Johannes
A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
title A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
title_full A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
title_fullStr A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
title_full_unstemmed A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
title_short A safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
title_sort safe and efficient 7‐week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078896/
https://www.ncbi.nlm.nih.gov/pubmed/31394011
http://dx.doi.org/10.1111/all.14012
work_keys_str_mv AT schrautzerchristoph asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT arztgradwohllisa asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT bokanovicdanijela asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT schwarzines asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT cerpesurban asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT kochlukas asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT herzogsereinaannik asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT laipoldkarin asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT binderbarbara asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT abererwerner asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT sturmgunterjohannes asafeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT schrautzerchristoph safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT arztgradwohllisa safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT bokanovicdanijela safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT schwarzines safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT cerpesurban safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT kochlukas safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT herzogsereinaannik safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT laipoldkarin safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT binderbarbara safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT abererwerner safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom
AT sturmgunterjohannes safeandefficient7weekimmunotherapyprotocolwithaluminumhydroxideadsorbedvespidvenom